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Abstract
Background: Pax6 is a transcription factor essential for normal development of the eyes and
nervous system. It has two major isoforms, Pax6 and Pax6(5a), and the ratios between their
expression levels vary within narrow limits. We tested the effects of overexpressing either one or
other isoform on endogenous Pax6 expression levels in Neuro2A and NIH3T3 cells.
Results: We found that both isoforms caused an up-regulation of endogenous Pax6 expression in
cells with (Neuro2A) or without (NIH3T3) constitutive Pax6 expression. Western blots showed
that cells stably transfected with constructs expressing either Pax6 or Pax6(5a) contained raised
levels of both Pax6 and Pax6(5a). Quantitative RT-PCR confirmed an increase in levels of Pax6(5a)
mRNA in cells containing Pax6-expressing constructs and an increase in levels of Pax6 mRNA in
cells containing Pax6(5a)-expressing constructs. The fact that the introduction of constructs
expressing only one isoform increased the cellular levels of not only that isoform but also the other
indicates that activation of the endogenous Pax6 locus occurred. The ratio between the levels of
the two isoforms was maintained close to physiological values. The overexpression of either
isoform in neuroblastoma (Neuro2A) cell lines also promoted morphological change and an
increase in β-III-tubulin expression, indicating an increase in neurogenesis.
Conclusion: Our results demonstrate that Pax6 can up-regulate production of Pax6 protein from
an entire intact endogenous Pax6 locus in its genomic environment. This adds to previous studies
showing that Pax6 can up-regulate reporter expression driven by isolated Pax6 regulatory
elements. Furthermore, our results suggest that an important function of positive feedback might
be to stabilise the relative levels of Pax6 and Pax6(5a).
Background
The Pax6 transcription factor contains a paired domain
and a homeodomain and is expressed in a complex spa-
tio-temporal pattern during development of the retina,
lens and cornea, in regions of the forebrain, hindbrain,
cerebellum and spinal cord, the olfactory system and in
pancreatic islet cells [1-6]. Haploinsufficiency for Pax6
function (Pax6+/-) in the mouse results in the Small eye
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(Sey) phenotype. Homozygotes (Pax6-/-) die perinatally
with no eyes, no nasal structures and many severe brain
abnormalities [4,6-17].PAX6 haploinsufficiency also
causes eye and brain defects in humans [18,19]
Pax6(5a) was the first isoform of the Pax6 gene to be
described [5] and is generated by the alternative splicing
of exon 5a. The inclusion of this exon disrupts the paired
domain and alters its DNA binding properties, potentially
allowing Pax6 to activate a different set of downstream
target genes [20,21] Although the function of the
Pax6(5a) isoform has not yet been determined, a number
of studies have attempted to address the phenotypic
implications of this alternative splicing event. For exam-
ple, in the eye, constitutive deletion of murine exon 5a
leads to iris hypoplasia, alongside defects in the develop-
ment of the cornea, lens and retina [22]. Conversely, over-
expression of Pax6(5a) in the mouse lens leads to the
formation of cataracts and up-regulation of a number of
cellular adhesion molecules [23], while Pax6(5a) overex-
pression in the chick retina induces hyperplasia of the
neural retina [24]. Evidence from studies in vertebrates
suggests that the functions of Pax6 and Pax6(5a) differ
[25-27], which mirrors differences between the functions
of their homologues in invertebrates [28,29].
Two promoters are thought to be responsible for the
majority of Pax6 expression. They are known as P0 and P1
in quail and mouse [30-33](.(and are homologous to PA
and PB in the human [34]. A series of experiments have
indicated that when these elements are isolated and
cloned into reporter plasmids they can be bound by Pax6
proteins themselves. Constructs expressing quail Pax6
homologues increase activity from constructs containing
reporter genes driven either by the P0 or by the P1 pro-
moter when these are introduced into quail neuroretina
cells [32,33] Similarly, human PAX6 proteins affect the
activity of isolated PB promoter, although the nature of
the effect varies between cell lines [34], and murine Pax6
proteins activate transcription of a reporter gene via P0
[35]. These studies suggest that Pax6 proteins might posi-
tively autoregulate the gene. A crucial step is to discover
the nature of Pax6 autoregulation in an intact locus rather
than isolated elements since, on this point, evidence is
currently very limited. Several studies have shown that
Pax6 is required in some regions of the embryo (the lens,
olfactory placodes and diencephalon) for Pax6 transcrip-
tion [1,35,36], but whether the introduction of Pax6 it is
sufficient to induce or upregulate expression from the
intact locus is not known.
To search for evidence of positive autoregulation of an
intact locus, we generated murine neuroblastoma and
fibroblast cell lines [37,38]. with stable integration of con-
structs generating either one or other of the major iso-
forms of Pax6 [Pax6 or Pax6(5a)].
Results
Neuro2A cells express Pax6 at low levels. Pax6 proteins
were not detected reliably with immunocytochemistry in
untransfected cells (Fig. 1C) but transfection with con-
structs expressing Pax6 or Pax6(5a) produced cells that
were strongly immunoreactive (examples of transiently
transfected cells are shown in Fig. 1A,B). Following selec-
tion, cell lines with stable integration of constructs
expressing either Pax6(5a) or Pax6 were generated. West-
ern blots showed that these over-expressing lines pro-
duced increased levels of Pax6 proteins (Fig. 2A). Pax6
proteins were only detectable in Western blots on control
Neuro2A lines when the amount of protein loaded per
lane was increased 5-fold (right-hand lane in Fig. 2A).
The ability of Pax6 over-expressing Neuro2A cells to dif-
ferentiate along a neuronal pathway was assessed, to
ascertain whether the responses of Neuro2A cells to an
increased Pax6 level mimicked known responses of pri-
mary cells to Pax6 over-expression. Pax6 regulates neuro-
nal differentiation and its over-expression in brain cells
promotes neurogenesis [39]. Neuro2A cells can spontane-
ously differentiate along a neuronal pathway in culture
[40] and we tested whether over-expression of Pax6 pro-
teins would promote this process. Following seeding onto
glass coverslips or plastic wells, the morphology of over-
expressing cells was altered from that of control cells, in
that they appeared larger and had longer neurites, and
their levels of expression of the neuronal marker β-III-
tubulin were higher (Fig. 3A,B). The percentage of cells
expressing the neuronal marker, β-III-tubulin, was higher
in all four over-expressing lines [two carrying Pax6 and
two carrying Pax6(5a) constructs] than in control lines
expressing green fluorescent protein (GFP) alone (i.e.
transfected with pEGFPN1) [Fig. 3C]. We conclude that
over-expression of Pax6 proteins promotes neurogenesis
in Neuro2A cells, as it does in primary brain cells [39].
We then quantified the levels of Pax6 expression in four
over-expressing Neuro2A cell lines and in a control
Neuro2A cell line using densitometry on Western blots of
a series of 3–4 protein extracts from each line (Fig. 2B).
The density of each Pax6 and Pax6(5a) band was reported
relative to that of the β-actin band for that lane and the
fold over-expression was calculated relative to a value of 1
for the Pax6 band in the control line. We found that stable
introduction of constructs expressing either Pax6 or
Pax6(5a) increased production of not only the corre-
sponding form of the protein, but also the other form
(Fig. 2B). The increased production of both forms follow-
ing introduction of constructs that could make only one
form indicates that endogenous production must have
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increased. The introduction of Pax6 expression constructs
(lines 3 and 4 in Fig. 2B) increased production of
Pax6(5a) but levels remained below those of Pax6. Intro-
duction of Pax6(5a) expression constructs (lines 1 and 2
in Fig. 2B) increased production of Pax6 to levels above
those of Pax6(5a) in one line and equal to those of
Pax6(5a) in the other. None of the cell lines expressed
more Pax6(5a) than Pax6. The Pax6:Pax6(5a) ratios in the
lines varied from 1.1:1 (line 2, Fig. 2B) to 6.0:1 (lines 1
and 4, Fig. 2B). We concluded that endogenous produc-
tion can respond positively to an increased level of either
Pax6 or Pax6(5a) protein and that the end-result is to
maintain Pax6:Pax6(5a) ratios close to those seen in brain
cells in vivo, which range from around 3:1 to around 10:1
depending on age and tissue type [41].
Quantitative PCR (Q-PCR) with primers specific to either
Pax6 or Pax6(5a) (Fig 4; sequences in Methods) was used
to demonstrate upregulation of Pax6(5a) mRNA in
Neuro2A cells transfected with the Pax6-expressing
contruct and vice-versa. Figure 5 shows average fold
increases in protein levels plotted against average fold
increases in mRNA levels for each of the four lines (3
repeats per cell line; increases were relative to the average
level in a control line, assigned a value of 1.0). There was
a positive correlation between the mRNA increase and the
protein increase. These data confirm upregulation of tran-
scription from the endogenous locus in response to intro-
duction of either Pax6 or Pax6(5a) expression constructs.
Pax6 proteins were never detected in untransfected
NIH3T3 cells (Fig. 6A) but, as for Neuro2A cells, were
found by immunocytochemistry in transfected cells (Fig.
6B,C). Western blots failed to detect Pax6 proteins and
RT-PCR failed to detect Pax6 mRNA in untransfected
NIH3T3 cells. In NIH3T3 cell lines with stable integration
of either Pax6 or Pax6(5a) expression constructs, mRNA
and protein for both isoforms were detected. Levels varied
from line to line but were generally comparable to those
in stably transfected Neuro2A lines. Whether the cells con-
tained a Pax6 expressing construct or a Pax6(5a) express-
ing construct, expression of the Pax6 isoform was always
higher than that of the Pax6(5a) isoform. The intensity of
the Pax6 and the Pax6(5a) bands in Westerns were meas-
ured relative to the highest intensity found, which was
assigned a value of 1.0. In cells containing Pax6 expressing
constructs, the average intensity of the Pax6 band was
0.64 ± 0.20 (sem) and of the Pax6(5a) band was 0.40 ±
0.15 (n = 6 lines). In cells containing Pax6(5a) expressing
constructs, the average intensity of the Pax6 band was
0.51 ± 0.18 and of the Pax6(5a) band was 0.26 ± 0.04 (n
= 4 lines). Pax6:Pax6(5a) ratios ranged from 1.4:1 to 4.0:1
in these cell lines. We concluded that the result of express-
ing either one or other isoform on the endogenous locus
Transfection of Neuro2A cells with Pax6(5a) and Pax6 expression constructsFigur  1
Transfection of Neuro2A cells with Pax6(5a) and Pax6 expression constructs. (A,B) Immunocytochemical detection 
of Pax6 proteins (green) following transient transfection of Neuro2A cells with Pax6(5a) or Pax6. (C) Untransfected Neuro2A 
cells do not express detectable levels of Pax6.
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Quantification of Pax6 and Pax6(5a) in over-expressing cell linesFigure 2
Quantification of Pax6 and Pax6(5a) in over-expressing cell lines. (A) Western blots showing Pax6(5a) and Pax6 pro-
duction in four over-expressing stably transfected lines (20 mg protein per lane). In control lines, Pax6 proteins were not 
detectable unless 100 mg of protein were loaded per lane. (B) Quantification by densitometry of over-expression of Pax6(5a) 
and Pax6 in four over-expressing cell lines: lines 1 and 2 contained Pax6(5a) constructs, lines 3 and 4 contained Pax6 con-
structs. All values were expressed relative to levels of Pax6 in a control cell line. Mean values ± SEMs are plotted for levels of 
Pax6(5a) (grey bars) and Pax6 (black bars); all values, given below the histograms, are significantly higher than in controls 
(unpaired Student's t-tests: p < 0.01).
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was the same in NIH3T3 cells as in Neuro2A cells. Intro-
duction of expression constructs into non-expressing cell
lines was sufficient to induce expression from the endog-
enous locus.
Discussion
We examined the effect of Pax6 proteins on Pax6 expres-
sion from its intact endogenous locus, rather than from
isolated regulatory sequences, by driving either Pax6 or
Pax(5a) protein from an integrated expression construct
in cells and measuring the levels of production of both
isoforms. We found that in cells containing a construct
over-producing either one isoform or the other, produc-
tion of both forms was increased within the cells. Since
increased production of the isoform that was not gener-
ated from the introduced construct must have come from
the endogenous locus, we concluded that under these
conditions PAX6 proteins are capable of positively regu-
lating an intact Pax6 locus. In a cell line that does not nor-
mally express Pax6, introduction of Pax6 or Pax6(5a) was
sufficient to activate the endogenous locus. It was interest-
ing to observe in these experiments that the ratio of the
two forms remained close to values observed in vivo [41-
45]. The induction from the endogenous locus of the iso-
form that was not introduced, which prevents non-physi-
ological distortion of the Pax6:Pax6(5a) ratio, might be
revealing the existence of an autoregulatory mechanism
controlling the relative levels of the two isoforms.
Pax6 affects several aspects of eye and brain development,
including progenitor cell proliferation and neuronal dif-
ferentiation [9,39] Studies of Pax6-/- mice have indicated
that Pax6 promotes proliferation during early cortical
neurogenesis, but may have the opposite effect in the
developing diencephalon, or indeed in the cortex at later
stages of neurogenesis [9,17] There is evidence that loss of
Pax6 promotes asymmetrical division and production of
neurons in the early cortex of Pax6-/- mice [9] but that later
neurogenesis is impaired in mutants [39]. In the retina,
loss of Pax6 accelerates neuronal differentiation [46].
Whereas Pax6 has an early role in patterning the develop-
ing nervous system [1,4,6], it later adopts an important
function in axon guidance [13,14].
The changing roles of Pax6 with age, and/or differences
between its function in different tissues, might be due at
Cell lines over-expressing Pax6(5a) or Pax6 show increased expression of a neuronal markerFigure 3
Cell lines over-expressing Pax6(5a) or Pax6 show increased expression of a neuronal marker. (A,B) β-III-tubulin 
expression in a control cells line and in a Pax6(5a) over-expressing cell line. (C) Quantification of β-III-tubulin expression in a 
control cell line and in four over-expressing lines: mean percentages of expressing cells (± SEMs) with results of unpaired Stu-
dent's t-tests against untransfected cells indicated above bars (* = p < 0.05, ** = p < 0.01, *** = p < 0.001).
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least in part to a shift in the relative concentrations of Pax6
and Pax6(5a) [41,47] Even relatively small changes in the
ratio might be important since stronger effects on gene
activity via Pax6 and Pax6(5a) consensus binding
sequences are observed if Pax6 and Pax6(5a) are intro-
duced into cultured cell lines at ratios of 1:1 or 8:1 rather
than at ratios of 2:1, 4:1 or 16:1 [47]. There is evidence
that the functions of Pax6 and Pax6(5a) differ in verte-
brates [25-27], as do their homologues in invertebrates
[28,29]. Studies of Pax6- and Pax6(5a)-related genes in
Drosophila melanogaster, ey/toy and eyg/toe, have shown that
they promote, respectively, differentiation and prolifera-
tion of eye precursor cells [28,29]. Overexpression of Pax6
and Pax6(5a) can alter the expression of different sets of
genes in mammals [26,27] Mammalian brain cells reduce
their proliferation in response to overexpression of Pax6
or Pax6(5a) and increase their neurogenesis in response to
overexpression of Pax6 [25]. Thus, regulation of the rela-
tive levels of the two isoforms is very important for nor-
mal development.
Conclusion
Our data show the intact Pax6 locus is subject to positive
autoregulation and suggest this might provide a mecha-
nism that stabilises the relative levels of the major iso-
forms of Pax6.
Methods
In vitro over-expression studies
Full-length Pax6 and Pax6(5a) cDNAs, obtained by RT-
PCR, were cloned into pCMV-Script (Stratagene) and
sequenced in both directions. Neuro2A cells (ECACC
89121404) and NIH3T3 cells (ECACC 93061524) were
maintained in Minimal Essential Medium supplemented
with 10% foetal bovine serum, 1% non-essential amino
acids, 1% L-glutamine and 1% penicillin streptomycin
(Gibco). Stable clones were created by transfection (using
Lipofectamine 2000; Invitrogen) with linearised Pax6,
Pax6(5a) expression plasmids or a GFP expression plas-
mid (pEGFPN1; Clontech) followed by selection with G-
418 at 500 µg·µl-1 (NIH3T3) and 600 µg·µl-1 (NIH3T3)
[37,38] Clones were tested for the anticipated effects of
over-expression on neuronal differentiation [39]. Cells
were seeded on glass coverslips or directly into polysty-
rene wells at 2.5 × 104 cells·cm-2. After 72 h, cells were
fixed in 4% paraformaldehyde, permeabilised in 100%
methanol at -20°C or 0.1% Triton X-100 at room temper-
ature for 10 minutes and reacted with anti-Pax6 (Develop-
mental Studies Hybridoma bank; 1:75) and anti-β-III-
tubulin (Sigma; 1:1000) primary antibodies. Secondary
antibodies were AlexaFluor 448- and 568- conjugated
anti-mouse IgG1 (Molecular Probes; 1:200); cells were
counterstained in TOPRO-3 (Molecular Probes; 1:5000)
and RNaseA (Sigma; 1:1000).
Western blots
Total protein was extracted by mechanical homogenisa-
tion of confluent cell cultures in 20 mM Tris-HCl, 2 mM
EDTA, 150 mM NaCl, 1% Triton-X100 with Complete
Protease Inhibitors (Roche) and quantified with the BCA
protein assay kit (Pierce). Proteins were resolved by dena-
turing SDS-PAGE on 12% tris-glycine gels (Invitrogen)
and transferred to PVDF membranes (BioRad). Antibod-
ies were anti-Pax6 serum 13 (S. Saule, Institut Curie, Paris,
Correlation between fold increase in mRNA and protein production from the endogenou  Pax6 locus in Neuro2A cellsFigure 5
Correlation between fold increase in mRNA and pro-
tein production from the endogenous Pax6 locus in 
Neuro2A cells. Graph shows data for production of Pax6 
following introduction of Pax6(5a) expressing construct and 
Pax6(5a) following introduction of Pax6 expressing con-
struct.
Q-PCR primers used to distinguish Pax6(5a) from Pax6Figure 4
Q-PCR primers used to distinguish Pax6(5a) from 
Pax6. One forward primer, "Pax6 exon 5F light", is used for 
both reactions, as it binds to sequence within exon 5 of the 
Pax6 cDNA. (A) The reverse primer "Pax6 exon 55aR light" 
anneals to sequence spanning the junction between exons 5 
and 5a. The 3' 3 bp of the primer, which are crucial for 
primer binding, cross the exon boundary. If exon 5a is 
absent, this primer can not bind. (B) The reverse primer 
"Pax6 exon 56R light" anneals to sequence spanning the junc-
tion between exons 5 and 6. The 3' 3 bp of the primer 
crosses the exon boundary. If exon 5a is present, this primer 
can not bind. Coloured bars: Pax6 exons. Arrows: Q-PCR 
primers.
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France; 8) and anti β-actin (Sigma; 1:5000) and were
detected with the ECL+ chemiluminescent system (Amer-
sham). The densities of bands on X-ray films were quanti-
fied using a GS-710 densitometer and Quantity One
software (BioRad).
Quantitative RT-PCR
Quantitative RT-PCRs were performed using an Opticon
DNA Engine, to determine the relative levels of Pax6 and
Pax6(5a) mRNA. Q-PCR reactions were optimised to pro-
ceed without the formation of primer dimmers or ectopic
bands, which would interfere with quantitation. PCRs
were carried out in the presence of SYBR Green (Qiagen).
After 35 PCR cycles, a melting curve of the PCR product
was obtained by measuring the fluorescence emitted at
decreasing temperature increments. A smooth sigmoid
was an indication that the only double-stranded DNA
present in the PCR product was dimerised product, and
no primer dimers or ectopic bands were contaminating
the reaction. Reaction conditions were optimised until a
smooth sigmoidal melting curve was seen after each reac-
tion. A calibration standard was created for each primer
set by serial dilution of the most concentrated DNA tem-
plate. The number of cycles after which the fluorescence of
a reaction rose above baseline was designated as the cycle
threshold, c(t). As more DNA was included in a reaction,
the c(t) dropped, and a calibration curve of volume of
DNA against c(t) was plotted. The c(t) of each sample
DNA was then plotted onto this calibration curve, thus
allowing relative DNA quantitation across PCR reactions.
Primers were designed to allow amplification of the Pax6
gene between exons 5 and 6 (Fig. 4). The "Pax6 Exon 5F
light" primer (5' GCT TGG TGG TGT CTT TGT CA 3')
binds within exon 5 of the Pax6 cDNA, and should bind
all Pax6 cDNA present in a sample. The "Pax6 Exon 56R
light" primer (5' TCA CAC AAC CGT TGG ATA CC 3')
takes advantage of the fact that primer binding specificity
is conferred by 3' sequence, to allow selective amplifica-
tion of the Pax6 splice form. 19 bp of this primer corre-
sponds to sequence in the 5' end of exon 6. The most 3'
residue, however, binds to the G residue at the 3' end of
exon 5. Thus, this primer can only bind target cDNA when
exon 5 is spliced directly onto exon 6, and exon 5a is
absent. The "Pax6 Exon 55aR light" primer (5' TTT GCA
TCT GCA TGG GTC T 3') spans the junction between
Transfection of NIH3T3 cells with Pax6(5a) and Pax6 expression constructsFigur  6
Transfection of NIH3T3 cells with Pax6(5a) and Pax6 expression constructs. (A) Untransfected cells do not express 
Pax6. (B,C) Immunocytochemical detection of Pax6 proteins (green) following transient transfection of with Pax6(5a) or Pax6.
BMC Developmental Biology 2006, 6:25 http://www.biomedcentral.com/1471-213X/6/25
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exons 5 and 5a, and can only bind to the Pax6(5a) splice
form. Product size were 131 bp for the Exon 5F light/Exon
56R light pair and 129 bp for the Exon 5F light/Exon 55aR
light pair.
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